Dihydrolipoamide dehydrogenase (DLD) is a novel molecular target of bortezomib

Yu Feng(Soochow University), Yuhuan Zheng(Sichuan University)
Cell Death and Disease
August 13, 2024
10.1038/s41419-024-06982-2
Cited by 5

Related Papers

High CFTR expression in philadelphia chromosome-positive acute leukemia protects and maintains continuous activation of BCR-ABL and related signaling pathways in combination with PP2A
|Oncotarget|2017|16
FADD regulates adipose inflammation, adipogenesis, and adipocyte survival
|Cell Death Discovery|2024|7
Mutant TP53 promotes invasion of lung cancer cells by regulating desmoglein 3
|Journal of Cancer Research and Clinical Oncology|2024|1